EP News Bureau

Gupta to succeed Umang Vohra as part of a planned leadership transition pending shareholder approval

The platform will be offered through insurers, brokers, and employers to help working professionals address early cardiometabolic…

The hold follows a serious safety event involving liver-related complications in a participant receiving the investigational…

Phase IIa data show faster infection resolution and shorter hospital stays when AP-SA02 is added to standard antibiotic therapy,…

Approval aligns Ticagrelor 60 mg with its reference drug Brilinta; estimated market size at US$ 236 million

Up to 100,000 ChAdOx1 NipahB doses to support Phase II trial and potential emergency outbreak response

LITESPARK-011 trial meets primary endpoint of progression-free survival in patients previously treated with anti-PD-1/L1 therapy

The Zambia-based facility will cover 40 acres, produce multiple dosage forms, and create more than 1,000 jobs as part of Akums’…

The company invests over INR 160 crores to expand its Bengaluru facility, supporting antibody research, innovation, and local…

The approval allows a simplified once-monthly 200 mg maintenance dose of Omvoh (mirikizumab-mrkz) for adults with moderately to…